[go: up one dir, main page]

AUPS329002A0 - Glycoalkaloid compositions and various uses thereof - Google Patents

Glycoalkaloid compositions and various uses thereof

Info

Publication number
AUPS329002A0
AUPS329002A0 AUPS3290A AUPS329002A AUPS329002A0 AU PS329002 A0 AUPS329002 A0 AU PS329002A0 AU PS3290 A AUPS3290 A AU PS3290A AU PS329002 A AUPS329002 A AU PS329002A AU PS329002 A0 AUPS329002 A0 AU PS329002A0
Authority
AU
Australia
Prior art keywords
various uses
glycoalkaloid
compositions
glycoalkaloid compositions
various
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPS3290A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Solbec Pharmaceuticals Ltd
Original Assignee
Solbec Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solbec Pharmaceuticals Ltd filed Critical Solbec Pharmaceuticals Ltd
Priority to AUPS3290A priority Critical patent/AUPS329002A0/en
Publication of AUPS329002A0 publication Critical patent/AUPS329002A0/en
Priority to CA002489675A priority patent/CA2489675A1/en
Priority to AU2003238544A priority patent/AU2003238544A1/en
Priority to PCT/AU2003/000788 priority patent/WO2004002497A1/en
Priority to NZ537267A priority patent/NZ537267A/en
Priority to EP03732115A priority patent/EP1539191A4/en
Priority to AU2009202266A priority patent/AU2009202266A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Pregnancy & Childbirth (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
AUPS3290A 2002-07-01 2002-07-01 Glycoalkaloid compositions and various uses thereof Abandoned AUPS329002A0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
AUPS3290A AUPS329002A0 (en) 2002-07-01 2002-07-01 Glycoalkaloid compositions and various uses thereof
CA002489675A CA2489675A1 (en) 2002-07-01 2003-06-24 Glycoalkaloid compositions and various uses thereof
AU2003238544A AU2003238544A1 (en) 2002-07-01 2003-06-24 Glycoalkaloid compositions and various uses thereof.
PCT/AU2003/000788 WO2004002497A1 (en) 2002-07-01 2003-06-24 Glycoalkaloid compositions and various uses thereof
NZ537267A NZ537267A (en) 2002-07-01 2003-06-24 Glycoalkaloid compositions and various uses thereof
EP03732115A EP1539191A4 (en) 2002-07-01 2003-06-24 Glycoalkaloid compositions and various uses thereof
AU2009202266A AU2009202266A1 (en) 2002-07-01 2009-06-08 Glycoalkaloid Compositions and Various Uses Thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPS3290A AUPS329002A0 (en) 2002-07-01 2002-07-01 Glycoalkaloid compositions and various uses thereof

Publications (1)

Publication Number Publication Date
AUPS329002A0 true AUPS329002A0 (en) 2002-07-18

Family

ID=3836847

Family Applications (3)

Application Number Title Priority Date Filing Date
AUPS3290A Abandoned AUPS329002A0 (en) 2002-07-01 2002-07-01 Glycoalkaloid compositions and various uses thereof
AU2003238544A Abandoned AU2003238544A1 (en) 2002-07-01 2003-06-24 Glycoalkaloid compositions and various uses thereof.
AU2009202266A Abandoned AU2009202266A1 (en) 2002-07-01 2009-06-08 Glycoalkaloid Compositions and Various Uses Thereof

Family Applications After (2)

Application Number Title Priority Date Filing Date
AU2003238544A Abandoned AU2003238544A1 (en) 2002-07-01 2003-06-24 Glycoalkaloid compositions and various uses thereof.
AU2009202266A Abandoned AU2009202266A1 (en) 2002-07-01 2009-06-08 Glycoalkaloid Compositions and Various Uses Thereof

Country Status (5)

Country Link
EP (1) EP1539191A4 (en)
AU (3) AUPS329002A0 (en)
CA (1) CA2489675A1 (en)
NZ (1) NZ537267A (en)
WO (1) WO2004002497A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003900194A0 (en) * 2003-01-15 2003-01-30 Solbec Pharmaceuticals Limited Methods of modulating il-6
GB0513881D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors III
US20080182801A1 (en) 2003-12-22 2008-07-31 Btg International Limited Core 2 glcnac-t inhibitors
GB0329667D0 (en) 2003-12-22 2004-01-28 King S College London Core 2 GlcNAc-T inhibitor
EP1858526A1 (en) * 2005-03-02 2007-11-28 Solbec Pharmaceuticals Limited Glycoalkaloid and tlr agonist combinations and various uses thereof
GB0513888D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors II
GB0513883D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Diagnosis of Atherosclerosis
WO2008064425A1 (en) * 2006-11-30 2008-06-05 Solbec Pharmaceuticals Limited Glycoalkaloid and chemotherapeutic agent combinations and various uses thereof
TWI414304B (en) * 2011-05-04 2013-11-11 G & E Herbal Biotechnology Co Ltd Treatment of wart with a water soluble extract from plant of solanum genus
TWI476012B (en) * 2011-05-12 2015-03-11 G & E Herbal Biotechnology Co Ltd Treatment and/or prevention of inflammation and cutaneous photodamage and photoprotection of the skin with a water soluble extract from plant of solanum genus
CN102872260A (en) * 2011-06-10 2013-01-16 德英生物科技股份有限公司 Use of water-soluble extracts of plants of the Solanum genus for the treatment and/or prevention of inflammation and photodamage of the skin and photoprotection of the skin
CN111303239B (en) * 2020-03-02 2022-03-01 河南中医药大学 Two active monomers, compositions for treating esophageal cancer and their applications
CN114306361A (en) * 2021-11-29 2022-04-12 成都大学 Use of Khasianine in the preparation of medicaments for preventing and/or treating inflammatory diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ193564A (en) * 1979-05-02 1985-01-31 Aruba Pty Ltd Steroid alkaloids from solanum sodomeum and pharmaceutical compositions
AU540812B2 (en) * 1979-05-02 1984-12-06 Aruba Qld Pty. Ltd. Steroid alkaloids
AU654474B2 (en) * 1990-01-18 1994-11-10 Cura Nominees Pty Ltd Glycoalkaloids
AU779512B2 (en) * 1999-04-09 2005-01-27 Cura Nominees Pty Ltd Medicinal compositions and their method of preparation
ES2253566T3 (en) * 2001-09-28 2006-06-01 Glycomed Sciences Limited EXTRACTION PROCEDURE WITH SOLVENTS.

Also Published As

Publication number Publication date
CA2489675A1 (en) 2004-01-08
WO2004002497A1 (en) 2004-01-08
EP1539191A4 (en) 2007-03-21
NZ537267A (en) 2006-11-30
AU2009202266A1 (en) 2009-08-06
AU2003238544A1 (en) 2004-01-19
EP1539191A1 (en) 2005-06-15

Similar Documents

Publication Publication Date Title
IL169441A0 (en) Hemostatic compositions and uses therefor
AU2003231107A1 (en) Detergent compositions and components thereof
AU2002357119A1 (en) Mitocidal compositions and methods
AU2001294814A1 (en) Pumpcn compositions and uses thereof
AU2003218121A1 (en) Lotion compositions
AU2003275268A1 (en) Hemostatic compositions and methods
AU2003269197A1 (en) Microbicidal compositions and their use
AUPS329002A0 (en) Glycoalkaloid compositions and various uses thereof
AU2003213120A1 (en) Human rnase iii and compositions and uses thereof
AU2002357748A1 (en) Osteopontin-related compositions and methods
GB2384705B (en) Cosmetic and related compositions
AU2003301902A1 (en) Cosmetic compositions
AUPR446801A0 (en) Novel compositions and uses therefor
AU2003231827A1 (en) Pseudo-tissues and uses thereof
AU2003228896A1 (en) Anti-microbial peptides and compositions
GB0207224D0 (en) Tenascin-W compositions and uses thereof
GB0325942D0 (en) Compositions and uses thereof
AU2003258772A1 (en) Novel neutracetical and pharmaceutical compositions and their uses
AU2003221567A1 (en) Hair conditioning compositions
AU2002359869A1 (en) Pak5-related compositions and methods
AU2002332244A1 (en) Demelanizing agents, beautifying agents, demelanizing compositions and beautifying compositions
AU2003206589A1 (en) Antihypertensive compositions and uses thereof
AUPS081202A0 (en) Compositions and uses therefor-iv
AUPS081002A0 (en) Compositions and uses therefor-11
AUPS080902A0 (en) Compositions and uses therefor-1